Pharmacogenetic analysis of the mGlu2/3 agonist LY2140023 monohydrate in the treatment of schizophrenia.
Liu W; Downing AC; Munsie LM; Chen P; Reed MR; Ruble CL; Landschulz KT; Kinon BJ; Nisenbaum LK; The Pharmacogenomics Journal, 2012, vol. 12, issue 3, p 246, ISSN 14731150. ISBN 14731150.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef